Stereoselective and regiospecific hydroxylation of ketamine and norketamine

References

• Adams JD Jr, Baillie TA, Trevor AJ, Castagnoli N Jr. (1981). Studies on the biotransformation of ketamine. 1-Identification of metabolites produced in vitro from rat liver microsomal preparations. Biomed Mass Spectrom 8:527–538.
   PubMedGoogle Scholar
• Angst MS, Clark JD. (2010). Ketamine for managing perioperative pain in opioid-dependent patients with chronic pain: a unique indication? Anesthesiology 113:514–515.
   PubMedGoogle Scholar
• Bolze S, Boulieu R. (1998). HPLC determination of ketamine, norketamine, and dehydronorketamine in plasma with a high-purity reversed-phase sorbent. Clin Chem 44:560–564.
   PubMedGoogle Scholar
• Chan WH, Sun WZ, Ueng TH. (2005). Induction of rat hepatic cytochrome P-450 by ketamine and its toxicological implications. J Toxicol Environ Health Part A 68:1581–1597.
   PubMed Web of Science ®Google Scholar
• Chen JT, Chen RM. (2010). Mechanisms of ketamine-involved regulation of cytochrome P450 gene expression. Expert Opin Drug Metab Toxicol 6:273–281.
   PubMed Web of Science ®Google Scholar
• Diazgranados N, Ibrahim L, Brutsche NE, Newberg A, Kronstein P, Khalife S, Kammerer WA, Quezado Z, Luckenbaugh DA, Salvadore G, Machado-Vieira R, Manji HK, Zarate CA Jr. (2010). A randomized add-on trial of an N-methyl-D-aspartate antagonist in treatment-resistant bipolar depression. Arch Gen Psychiatry 67:793–802.
   PubMed Web of Science ®Google Scholar
• Domino EF. (2010). Taming the ketamine tiger. 1965. Anesthesiology 113:678–684.
   PubMed Web of Science ®Google Scholar
• Goldberg ME, Torjman MC, Schwartzman RJ, Mager DE, Wainer IW. (2010). Pharmacodynamic profiles of ketamine ®- and (S)- with 5-day inpatient infusion for the treatment of complex regional pain syndrome. Pain Physician 13:379–387.
   PubMed Web of Science ®Google Scholar
• Goldberg ME, Torjman MC, Schwartzman RJ, Mager DE, Wainer IW. (2011). Enantioselective pharmacokinetics of ®- and (S)-ketamine after a 5-day infusion in patients with complex regional pain syndrome. Chirality 23:138–143.
   PubMed Web of Science ®Google Scholar
• Hijazi Y, Boulieu R. (2002). Contribution of CYP3A4, CYP2B6, and CYP2C9 isoforms to N-demethylation of ketamine in human liver microsomes. Drug Metab Dispos 30:853–858.
   PubMed Web of Science ®Google Scholar
• Kharasch ED, Labroo R. (1992). Metabolism of ketamine stereoisomers by human liver microsomes. Anesthesiology 77:1201–1207.
   PubMed Web of Science ®Google Scholar
• Kharasch ED, Herrmann S, Labroo R. (1992). Ketamine as a probe for medetomidine stereoisomer inhibition of human liver microsomal drug metabolism. Anesthesiology 77:1208–1214.
   PubMedGoogle Scholar
• Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. (2011). DrugBank 3.0: a comprehensive resource for ‘omics’ research on drugs. Nucleic Acids Res 39:D1035–D1041.
   PubMed Web of Science ®Google Scholar
• Lester L, Braude DA, Niles C, Crandall CS. (2010). Low-dose ketamine for analgesia in the ED: a retrospective case series. Am J Emerg Med 28:820–827.
   PubMed Web of Science ®Google Scholar
• Leung LY, Baillie TA. (1986). Comparative pharmacology in the rat of ketamine and its two principal metabolites, norketamine and (Z)-6-hydroxynorketamine. J Med Chem 29:2396–2399.
   PubMed Web of Science ®Google Scholar
• Lester L, Braude DA, Niles C, Crandall CS. (2010). Low-dose ketamine for analgesia in the ED: a retrospective case series. Am J Emerg Med 28:820–827.
   PubMed Web of Science ®Google Scholar
• Loftus RW, Yeager MP, Clark JA, Brown JR, Abdu WA, Sengupta DK, Beach ML. (2010). Intraoperative ketamine reduces perioperative opiate consumption in opiate-dependent patients with chronic back pain undergoing back surgery. Anesthesiology 113:639–646.
   PubMed Web of Science ®Google Scholar
• Matzke GR, Frye RF, Early JJ, Straka RJ, Carson SW. (2000). Evaluation of the influence of diabetes mellitus on antipyrine metabolism and CYP1A2 and CYP2D6 activity. Pharmacotherapy 20:182–190.
   PubMed Web of Science ®Google Scholar
• Moaddel R, Venkata SL, Tanga MJ, Bupp JE, Green CE, Iyer L, Furimsky A, Goldberg ME, Torjman MC, Wainer IW. (2010). A parallel chiral-achiral liquid chromatographic method for the determination of the stereoisomers of ketamine and ketamine metabolites in the plasma and urine of patients with complex regional pain syndrome. Talanta 82:1892–1904.
   PubMed Web of Science ®Google Scholar
• Nama S, Meenan DR, Fritz WT. (2010). The use of sub-anesthetic intravenous ketamine and adjuvant dexmedetomidine when treating acute pain from CRPS. Pain Physician 13:365–368.
   PubMedGoogle Scholar
• Noppers I, Olofsen E, Niesters M, Aarts L, Mooren R, Dahan A, Kharasch E, Sarton E. (2011). Effect of rifampicin on S-ketamine and S-norketamine plasma concentrations in healthy volunteers after intravenous S-ketamine administration. Anesthesiology 114:1435–1445.
   PubMed Web of Science ®Google Scholar
• O’Neil WM, Gilfix BM, DiGirolamo A, Tsoukas CM, Wainer IW. (1997). N-acetylation among HIV-positive patients and patients with AIDS: when is fast, fast and slow, slow? Clin Pharmacol Ther 62:261–271.
   PubMed Web of Science ®Google Scholar
• Portmann S, Kwan HY, Theurillat R, Schmitz A, Mevissen M, Thormann W. (2010). Enantioselective capillary electrophoresis for identification and characterization of human cytochrome P450 enzymes which metabolize ketamine and norketamine in vitro. J Chromatogr A 1217:7942–7948.
   PubMed Web of Science ®Google Scholar
• Renton KW. (2005). Regulation of drug metabolism and disposition during inflammation and infection. Expert Opin Drug Metab Toxicol 1:629–640.
   PubMedGoogle Scholar
• Sabia M, Hirsh RA, Torjman MC, Wainer IW, Cooper N, Domsky R, Goldberg ME. (2011). Advances in translational neuropathic research: example of enantioselective pharmacokinetic-pharmacodynamic modeling of ketamine-induced pain relief in complex regional pain syndrome. Curr Pain Headache Rep 15:207–214.
   PubMedGoogle Scholar
• Seripa D, Pilotto A, Panza F, Matera MG, Pilotto A. (2010). Pharmacogenetics of cytochrome P450 (CYP) in the elderly. Ageing Res Rev 9:457–474.
   PubMed Web of Science ®Google Scholar
• Sigtermans M, Dahan A, Mooren R, Bauer M, Kest B, Sarton E, Olofsen E. (2009). S(+)-ketamine effect on experimental pain and cardiac output: a population pharmacokinetic-pharmacodynamic modeling study in healthy volunteers. Anesthesiology 111:892–903.
   PubMed Web of Science ®Google Scholar
• Tanaka E. (1998). In vivo age-related changes in hepatic drug-oxidizing capacity in humans. J Clin Pharm Ther 23:247–255.
   PubMed Web of Science ®Google Scholar
• Trevor AJ, Woolf TF, Baillie TA, Adams JD, Castagnoli N. (1983). Stereoselective metabolism of ketamine enantiomers.. In: Kamenka JM, Domino EF, Geneste P, ed. Phencyclidine and Related Arylcyclohexylamines, Present and Future Applications. Ann Arbor, MI: NPP Books, 279–289.
   Google Scholar
• Turfus SC, Parkin MC, Cowan DA, Halket JM, Smith NW, Braithwaite RA, Elliot SP, Steventon GB, Kicman AT. (2009). Use of human microsomes and deuterated substrates: an alternative approach for the identification of novel metabolites of ketamine by mass spectrometry. Drug Metab Dispos 37:1769–1778.
   PubMed Web of Science ®Google Scholar
• Wang Z, Hall SD, Maya JF, Li L, Asghar A, Gorski JC. (2003). Diabetes mellitus increases the in vivo activity of cytochrome P450 2E1 in humans. Br J Clin Pharmacol 55:77–85.
   PubMed Web of Science ®Google Scholar
• Williams ML, Wainer IW. (2002). Genotype/phenotype comparisons: a probe for the effect of disease progression on drug metabolism. Curr Opin Drug Discov Devel 5:144–149.
   PubMedGoogle Scholar
• Williams ML, Mager DE, Parenteau H, Gudi G, Tracy TS, Mulheran M, Wainer IW. (2004). Effects of protein calorie malnutrition on the pharmacokinetics of ketamine in rats. Drug Metab Dispos 32:786–793.
   PubMedGoogle Scholar
• Woolf TF, Adams JD. (1987). Biotransformation of ketamine, (Z)-6-hydroxyketamine, and (E)-6-hydroxyketamine by rat, rabbit, and human liver microsomal preparations. Xenobiotica 17:839–847.
   PubMed Web of Science ®Google Scholar
• Zhao X, Venkata SLV, Moaddel R, Luckenbaugh DA, Brutsche NE, Ibrahim L, Zarate CA Jr., Mager DE, Wainer IW. (2012). Simultaneous population pharmacokinetic modeling of ketamine and three major metabolites in patients with treatment-resistant bipolar depression. Br J Clin Pharmacol. DOI: 10.1111/j.1365-2125.2012.04198.x.
   Google Scholar
• Zarate CA Jr, Brutsche N, Laje G, Luckenbaugh DA, Venkata SLV, Ramamoorthy A, Moaddel R, Wainer IW. (2012). Relationship of ketamine’s plasma metabolites with response, diagnosis, and side effects in major depression. Biol Psychiatry, http://dx.doi.org/10.1016/j.biopsych.2012.03.004.
   Google Scholar